Skip to main content

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

Erratum

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all co-authors. The full list of authors and the corrected Authors Contributions section are reported below. We apologize for any inconvenience this oversight may have caused.

Corrected Authors’ List

Alain Hendlisz1*, Vassilis Golfinopoulos1, Amelie Deleporte1, Marianne Paesmans2, Hazem El Mansy1, Camilo Garcia3, Marc Peeters4, Lieven Annemans5, Caroline Vandeputte1, Marion Maetens1, Marc Van den Eynde6, Raphaël Maréchal10, Ivan Borbath6, Damien Dresse7, Ghislain Houbiers8, Michael Fried9, Ahmad Awada1, Martine Piccart1, Jean-Luc Van Laethem10 and Patrick Flamen3

Corrected Authors' contributions

AH, PM, VG Contribution to protocol writing, Manuscript design, Setting-up the trial, Writing manuscript; HEM, AD, CV, MM, MVDE, RM, Writing manuscript; CG, PF, Contribution to protocol writing, Manuscript design, Setting-up the trial, Writing manuscript, Coordination of PET imaging network; PM, AA, MP, Contribution to protocol writing, Setting-up the trial; JVL, Contribution to protocol writing, Setting-up the trial, Writing manuscript. All authors read and approved the final manuscript.

Reference

  1. 1.

    Alain H, Vassilis G, Amelie D, Marianne P, Hazem El M, Camilo G, et al. Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer. 2013;13:190.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alain Hendlisz.

Additional information

The online version of the original article can be found under doi:10.1186/1471-2407-13-190.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hendlisz, A., Golfinopoulos, V., Deleporte, A. et al. Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer 15, 173 (2015). https://doi.org/10.1186/s12885-015-1181-5

Download citation